Delivery Order SPE2DB22D3501-SPE2DB25FXH47
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Fluticasone Propionate HFA 220 mcg inhalers in 12-gram quantities. This firm fixed-price delivery order, valued at $14,846.64 with an ultimate completion date of August 11, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, valued at $1,184.52, with an ultimate completion date of August 4, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor and critical vendor for federal...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,532.28 for Fluticasone Propionate HFA 110 MCG inhalers (12GM units), with an ultimate completion date of August 11, 2025. This contract was competitively awarded on August 8, 2025, under a firm fixed-price arrangement with no set-aside designation. The delivery order was placed to AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,545.00 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 MCG 12GM inhalers. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 4, 2025. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a ceiling value of $1,504.06. This firm fixed-price delivery order, which was competitively awarded without a set-aside designation, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework. The contract specifies Conshohocken, Pennsylvania as the place of...
- The Defense Logistics Agency awarded a delivery order valued at $18,447.48 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 MCG 12GM inhalers, with performance at the company's Conshohocken, Pennsylvania facility. This non-competitive, firm fixed-price delivery order was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $1,709.66 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 mcg inhalers (12 gm units) on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,715.83 on July 29, 2025, for the supply of Fluticasone Propionate HFA 44 microgram inhalers (10.6 grams). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $3,242.06 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 MCG inhalers (12-gram units) on August 18, 2025, with completion scheduled for August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,451.00 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 44 MCG 10.6GM inhalers. This contract, which was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a firm fixed-price delivery order executed without a set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office...